Click for best price
Radioimmunotherapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Radioimmunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioimmunotherapy. This report contains market size and forecasts of Radioimmunotherapy in global, including the following market information:
Global Radioimmunotherapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Radioimmunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Non Hodgkin Lymphoma (NHL) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Radioimmunotherapy include Bayer Healthcare Pharmaceuticals, BioSynthema, Clarity Pharmaceuticals, Curasight, Endocyte, Immunomedics, Molecular Insight Pharmaceuticals, Nordic Nanovector and PDL Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioimmunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioimmunotherapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Type, 2022 (%)
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Global Radioimmunotherapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Application, 2022 (%)
Tumor Antigens
Radionuclides
Antibodies
Global Radioimmunotherapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Radioimmunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioimmunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radioimmunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radioimmunotherapy, market overview.
Chapter 2: Global Radioimmunotherapy market size in revenue.
Chapter 3: Detailed analysis of Radioimmunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioimmunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Radioimmunotherapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radioimmunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioimmunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioimmunotherapy Overall Market Size
2.1 Global Radioimmunotherapy Market Size: 2022 VS 2030
2.2 Global Radioimmunotherapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioimmunotherapy Players in Global Market
3.2 Top Global Radioimmunotherapy Companies Ranked by Revenue
3.3 Global Radioimmunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Radioimmunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radioimmunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioimmunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Radioimmunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioimmunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radioimmunotherapy Market Size Markets, 2022 & 2030
4.1.2 Non Hodgkin Lymphoma (NHL)
4.1.3 Follicular Lymphoma
4.1.4 Solid Tumors
4.1.5 Breast Cancer
4.1.6 Ovarian Cancer
4.1.7 Osteosarcoma
4.1.8 Neuroblastoma
4.1.9 Prostate Cancer
4.2 By Type - Global Radioimmunotherapy Revenue & Forecasts
4.2.1 By Type - Global Radioimmunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Radioimmunotherapy Revenue, 2024-2030
4.2.3 By Type - Global Radioimmunotherapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioimmunotherapy Market Size, 2022 & 2030
5.1.2 Tumor Antigens
5.1.3 Radionuclides
5.1.4 Antibodies
5.2 By Application - Global Radioimmunotherapy Revenue & Forecasts
5.2.1 By Application - Global Radioimmunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Radioimmunotherapy Revenue, 2024-2030
5.2.3 By Application - Global Radioimmunotherapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Radioimmunotherapy Market Size, 2022 & 2030
6.2 By Region - Global Radioimmunotherapy Revenue & Forecasts
6.2.1 By Region - Global Radioimmunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Radioimmunotherapy Revenue, 2024-2030
6.2.3 By Region - Global Radioimmunotherapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Radioimmunotherapy Revenue, 2018-2030
6.3.2 US Radioimmunotherapy Market Size, 2018-2030
6.3.3 Canada Radioimmunotherapy Market Size, 2018-2030
6.3.4 Mexico Radioimmunotherapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Radioimmunotherapy Revenue, 2018-2030
6.4.2 Germany Radioimmunotherapy Market Size, 2018-2030
6.4.3 France Radioimmunotherapy Market Size, 2018-2030
6.4.4 U.K. Radioimmunotherapy Market Size, 2018-2030
6.4.5 Italy Radioimmunotherapy Market Size, 2018-2030
6.4.6 Russia Radioimmunotherapy Market Size, 2018-2030
6.4.7 Nordic Countries Radioimmunotherapy Market Size, 2018-2030
6.4.8 Benelux Radioimmunotherapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Radioimmunotherapy Revenue, 2018-2030
6.5.2 China Radioimmunotherapy Market Size, 2018-2030
6.5.3 Japan Radioimmunotherapy Market Size, 2018-2030
6.5.4 South Korea Radioimmunotherapy Market Size, 2018-2030
6.5.5 Southeast Asia Radioimmunotherapy Market Size, 2018-2030
6.5.6 India Radioimmunotherapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Radioimmunotherapy Revenue, 2018-2030
6.6.2 Brazil Radioimmunotherapy Market Size, 2018-2030
6.6.3 Argentina Radioimmunotherapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioimmunotherapy Revenue, 2018-2030
6.7.2 Turkey Radioimmunotherapy Market Size, 2018-2030
6.7.3 Israel Radioimmunotherapy Market Size, 2018-2030
6.7.4 Saudi Arabia Radioimmunotherapy Market Size, 2018-2030
6.7.5 UAE Radioimmunotherapy Market Size, 2018-2030
7 Radioimmunotherapy Companies Profiles
7.1 Bayer Healthcare Pharmaceuticals
7.1.1 Bayer Healthcare Pharmaceuticals Company Summary
7.1.2 Bayer Healthcare Pharmaceuticals Business Overview
7.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.1.4 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Healthcare Pharmaceuticals Key News & Latest Developments
7.2 BioSynthema
7.2.1 BioSynthema Company Summary
7.2.2 BioSynthema Business Overview
7.2.3 BioSynthema Radioimmunotherapy Major Product Offerings
7.2.4 BioSynthema Radioimmunotherapy Revenue in Global Market (2018-2023)
7.2.5 BioSynthema Key News & Latest Developments
7.3 Clarity Pharmaceuticals
7.3.1 Clarity Pharmaceuticals Company Summary
7.3.2 Clarity Pharmaceuticals Business Overview
7.3.3 Clarity Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.3.4 Clarity Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2018-2023)
7.3.5 Clarity Pharmaceuticals Key News & Latest Developments
7.4 Curasight
7.4.1 Curasight Company Summary
7.4.2 Curasight Business Overview
7.4.3 Curasight Radioimmunotherapy Major Product Offerings
7.4.4 Curasight Radioimmunotherapy Revenue in Global Market (2018-2023)
7.4.5 Curasight Key News & Latest Developments
7.5 Endocyte
7.5.1 Endocyte Company Summary
7.5.2 Endocyte Business Overview
7.5.3 Endocyte Radioimmunotherapy Major Product Offerings
7.5.4 Endocyte Radioimmunotherapy Revenue in Global Market (2018-2023)
7.5.5 Endocyte Key News & Latest Developments
7.6 Immunomedics
7.6.1 Immunomedics Company Summary
7.6.2 Immunomedics Business Overview
7.6.3 Immunomedics Radioimmunotherapy Major Product Offerings
7.6.4 Immunomedics Radioimmunotherapy Revenue in Global Market (2018-2023)
7.6.5 Immunomedics Key News & Latest Developments
7.7 Molecular Insight Pharmaceuticals
7.7.1 Molecular Insight Pharmaceuticals Company Summary
7.7.2 Molecular Insight Pharmaceuticals Business Overview
7.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.7.4 Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2018-2023)
7.7.5 Molecular Insight Pharmaceuticals Key News & Latest Developments
7.8 Nordic Nanovector
7.8.1 Nordic Nanovector Company Summary
7.8.2 Nordic Nanovector Business Overview
7.8.3 Nordic Nanovector Radioimmunotherapy Major Product Offerings
7.8.4 Nordic Nanovector Radioimmunotherapy Revenue in Global Market (2018-2023)
7.8.5 Nordic Nanovector Key News & Latest Developments
7.9 PDL Biopharma
7.9.1 PDL Biopharma Company Summary
7.9.2 PDL Biopharma Business Overview
7.9.3 PDL Biopharma Radioimmunotherapy Major Product Offerings
7.9.4 PDL Biopharma Radioimmunotherapy Revenue in Global Market (2018-2023)
7.9.5 PDL Biopharma Key News & Latest Developments
7.10 Philogen
7.10.1 Philogen Company Summary
7.10.2 Philogen Business Overview
7.10.3 Philogen Radioimmunotherapy Major Product Offerings
7.10.4 Philogen Radioimmunotherapy Revenue in Global Market (2018-2023)
7.10.5 Philogen Key News & Latest Developments
7.11 RadioMedix
7.11.1 RadioMedix Company Summary
7.11.2 RadioMedix Business Overview
7.11.3 RadioMedix Radioimmunotherapy Major Product Offerings
7.11.4 RadioMedix Radioimmunotherapy Revenue in Global Market (2018-2023)
7.11.5 RadioMedix Key News & Latest Developments
7.12 Stella Pharma
7.12.1 Stella Pharma Company Summary
7.12.2 Stella Pharma Business Overview
7.12.3 Stella Pharma Radioimmunotherapy Major Product Offerings
7.12.4 Stella Pharma Radioimmunotherapy Revenue in Global Market (2018-2023)
7.12.5 Stella Pharma Key News & Latest Developments
7.13 Telix Pharmaceuticals
7.13.1 Telix Pharmaceuticals Company Summary
7.13.2 Telix Pharmaceuticals Business Overview
7.13.3 Telix Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.13.4 Telix Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2018-2023)
7.13.5 Telix Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radioimmunotherapy Market Opportunities & Trends in Global Market
Table 2. Radioimmunotherapy Market Drivers in Global Market
Table 3. Radioimmunotherapy Market Restraints in Global Market
Table 4. Key Players of Radioimmunotherapy in Global Market
Table 5. Top Radioimmunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Radioimmunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Radioimmunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Radioimmunotherapy Product Type
Table 9. List of Global Tier 1 Radioimmunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radioimmunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Radioimmunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Radioimmunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Radioimmunotherapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Radioimmunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Radioimmunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Radioimmunotherapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Radioimmunotherapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Radioimmunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Radioimmunotherapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Radioimmunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Radioimmunotherapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Radioimmunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Radioimmunotherapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Radioimmunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Radioimmunotherapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Radioimmunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Radioimmunotherapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Radioimmunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Radioimmunotherapy Revenue, (US$, Mn), 2024-2030
Table 30. Bayer Healthcare Pharmaceuticals Company Summary
Table 31. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product Offerings
Table 32. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Healthcare Pharmaceuticals Key News & Latest Developments
Table 34. BioSynthema Company Summary
Table 35. BioSynthema Radioimmunotherapy Product Offerings
Table 36. BioSynthema Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. BioSynthema Key News & Latest Developments
Table 38. Clarity Pharmaceuticals Company Summary
Table 39. Clarity Pharmaceuticals Radioimmunotherapy Product Offerings
Table 40. Clarity Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Clarity Pharmaceuticals Key News & Latest Developments
Table 42. Curasight Company Summary
Table 43. Curasight Radioimmunotherapy Product Offerings
Table 44. Curasight Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Curasight Key News & Latest Developments
Table 46. Endocyte Company Summary
Table 47. Endocyte Radioimmunotherapy Product Offerings
Table 48. Endocyte Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Endocyte Key News & Latest Developments
Table 50. Immunomedics Company Summary
Table 51. Immunomedics Radioimmunotherapy Product Offerings
Table 52. Immunomedics Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Immunomedics Key News & Latest Developments
Table 54. Molecular Insight Pharmaceuticals Company Summary
Table 55. Molecular Insight Pharmaceuticals Radioimmunotherapy Product Offerings
Table 56. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Molecular Insight Pharmaceuticals Key News & Latest Developments
Table 58. Nordic Nanovector Company Summary
Table 59. Nordic Nanovector Radioimmunotherapy Product Offerings
Table 60. Nordic Nanovector Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Nordic Nanovector Key News & Latest Developments
Table 62. PDL Biopharma Company Summary
Table 63. PDL Biopharma Radioimmunotherapy Product Offerings
Table 64. PDL Biopharma Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. PDL Biopharma Key News & Latest Developments
Table 66. Philogen Company Summary
Table 67. Philogen Radioimmunotherapy Product Offerings
Table 68. Philogen Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. Philogen Key News & Latest Developments
Table 70. RadioMedix Company Summary
Table 71. RadioMedix Radioimmunotherapy Product Offerings
Table 72. RadioMedix Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 73. RadioMedix Key News & Latest Developments
Table 74. Stella Pharma Company Summary
Table 75. Stella Pharma Radioimmunotherapy Product Offerings
Table 76. Stella Pharma Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 77. Stella Pharma Key News & Latest Developments
Table 78. Telix Pharmaceuticals Company Summary
Table 79. Telix Pharmaceuticals Radioimmunotherapy Product Offerings
Table 80. Telix Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn) & (2018-2023)
Table 81. Telix Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Radioimmunotherapy Segment by Type in 2022
Figure 2. Radioimmunotherapy Segment by Application in 2022
Figure 3. Global Radioimmunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radioimmunotherapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Radioimmunotherapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radioimmunotherapy Revenue in 2022
Figure 8. By Type - Global Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Radioimmunotherapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Radioimmunotherapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 16. US Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 20. Germany Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 28. China Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 34. Brazil Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Radioimmunotherapy Revenue Market Share, 2018-2030
Figure 37. Turkey Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Radioimmunotherapy Revenue, (US$, Mn), 2018-2030
Figure 41. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioSynthema Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Clarity Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Curasight Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Endocyte Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Immunomedics Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nordic Nanovector Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. PDL Biopharma Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Philogen Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. RadioMedix Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Stella Pharma Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Telix Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
